TR199501599A2 - 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri. - Google Patents

17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri.

Info

Publication number
TR199501599A2
TR199501599A2 TR95/01599A TR9501599A TR199501599A2 TR 199501599 A2 TR199501599 A2 TR 199501599A2 TR 95/01599 A TR95/01599 A TR 95/01599A TR 9501599 A TR9501599 A TR 9501599A TR 199501599 A2 TR199501599 A2 TR 199501599A2
Authority
TR
Turkey
Prior art keywords
delivery
drug administration
administration devices
intravaginal drug
oestradiol precursor
Prior art date
Application number
TR95/01599A
Other languages
English (en)
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of TR199501599A2 publication Critical patent/TR199501599A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
TR95/01599A 1994-12-19 1995-12-19 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri. TR199501599A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05

Publications (1)

Publication Number Publication Date
TR199501599A2 true TR199501599A2 (tr) 1996-07-21

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01599A TR199501599A2 (tr) 1994-12-19 1995-12-19 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri.

Country Status (19)

Country Link
US (1) US5855906A (tr)
EP (1) EP0799025B1 (tr)
JP (1) JPH10510825A (tr)
CN (1) CN1138526C (tr)
AR (1) AR002010A1 (tr)
AT (1) ATE178204T1 (tr)
AU (1) AU692659B2 (tr)
CA (1) CA2207622C (tr)
DE (1) DE69508791T2 (tr)
DK (1) DK0799025T3 (tr)
ES (1) ES2133841T3 (tr)
FI (1) FI119414B (tr)
GR (1) GR3030614T3 (tr)
IL (1) IL116433A (tr)
NO (1) NO316707B1 (tr)
NZ (1) NZ298490A (tr)
PE (1) PE62796A1 (tr)
TR (1) TR199501599A2 (tr)
WO (1) WO1996019196A1 (tr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
DE69809222T2 (de) 1997-05-07 2003-08-14 Galen (Chemicals) Ltd., Dublin Vorrichtungen zur intravaginalen verabreichung von testosteron und testosteron-vorläuferverbindungen
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) * 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
US7833545B2 (en) * 2003-04-29 2010-11-16 The General Hospital Corporation Methods and devices for the sustained release of multiple drugs
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
US20060183724A1 (en) * 2005-02-03 2006-08-17 Diliberti Charles E Compositions of unconjugated estrogens and methods for their use
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
EP1933810B1 (en) 2005-08-11 2012-10-10 Massachusetts Institute of Technology Intravesical drug delivery device and method
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
US8900620B2 (en) 2005-10-13 2014-12-02 DePuy Synthes Products, LLC Drug-impregnated encasement
GB0613333D0 (en) * 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
WO2008007098A2 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
SG195525A1 (en) * 2007-06-26 2013-12-30 Warner Chilcott Co Llc Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
EA201070703A1 (ru) 2007-12-11 2010-12-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарства и способы лечения мочевого пузыря и других полостей тела или трубчатых органов
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
CA2765630C (en) 2009-06-26 2016-07-05 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
JP2014503554A (ja) 2011-01-10 2014-02-13 タリス バイオメディカル，インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
ES2637388T3 (es) 2011-02-04 2017-10-13 Taris Biomedical, Inc. Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad
RU2740680C2 (ru) 2011-09-14 2021-01-19 Форсайт Вижн5, Инк. Глазное вкладочное устройство и способы
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
EP2911623B1 (en) 2012-10-26 2019-08-14 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
PL2968880T3 (pl) 2013-03-15 2025-06-23 Taris Biomedical Llc Urządzenia do dostarczania leku ze składnikiem przepuszczalnym dla leku
AU2014281010B2 (en) 2013-06-21 2018-05-10 DePuy Synthes Products, Inc. Films and methods of manufacture
IL299897B2 (en) 2013-08-19 2024-02-01 Taris Biomedical Llc Devices and methods for administering multiple units of drug
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
JP6667450B2 (ja) * 2014-04-01 2020-03-18 ポリ−メッド インコーポレイテッド 避妊具及び関連した器具
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
EP4744688A2 (en) 2015-04-23 2026-05-20 Janssen Biotech Inc DRUG DELIVERY DEVICES WITH A DRUG-PERMEABLE COMPONENT AND METHODS
CN114573654B (zh) * 2020-12-01 2025-09-12 北京奇明达企业管理有限公司 17-O-乙酰-17-β雌二醇的自组装的三聚体、其制备、活性和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
NO972798D0 (no) 1997-06-17
JPH10510825A (ja) 1998-10-20
CA2207622C (en) 2006-10-17
FI972579L (fi) 1997-06-17
DE69508791D1 (de) 1999-05-06
IL116433A0 (en) 1996-03-31
FI119414B (fi) 2008-11-14
FI972579A0 (fi) 1997-06-17
ES2133841T3 (es) 1999-09-16
PE62796A1 (es) 1996-12-28
AR002010A1 (es) 1998-01-07
CN1170353A (zh) 1998-01-14
DE69508791T2 (de) 1999-12-02
GR3030614T3 (en) 1999-10-29
NO972798L (no) 1997-08-19
CN1138526C (zh) 2004-02-18
WO1996019196A1 (en) 1996-06-27
ATE178204T1 (de) 1999-04-15
IL116433A (en) 2002-02-10
EP0799025B1 (en) 1999-03-31
US5855906A (en) 1999-01-05
DK0799025T3 (da) 1999-10-18
NO316707B1 (no) 2004-04-13
EP0799025A1 (en) 1997-10-08
NZ298490A (en) 1999-11-29
AU4399196A (en) 1996-07-10
CA2207622A1 (en) 1996-06-27
AU692659B2 (en) 1998-06-11

Similar Documents

Publication Publication Date Title
IL116433A0 (en) Intravaginal drug delivery devices for the administration of 17B-oestradiol precursors
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
ATE209497T1 (de) Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
GB9522403D0 (en) Intravaginal drug delivery device
TR27244A (tr) Ilac dagitim aleti.
NO20004196L (no) Innretninger for legemiddelavlevering
IL149663A0 (en) Devices for the delivery of drugs having antiprogestinic properties
DZ1876A1 (fr) Médicaments pour administration orale.
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
DK1221919T3 (da) Oftalmisk lægemiddeladministrationsanordning
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
HUP0201637A3 (en) Novel preparation and administration form comprising an acid-labile active compound
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
IT1284049B1 (it) Medicamento per somministrazione nasale
NO20001219D0 (no) Blanding for medikament-administrasjon
ITMI921022A1 (it) Procedimento per la preparazione di una forma liquida stabile di medicamenti contenenti beta-bloccanti con liberazione controllata del principio attivo per la somministrazione orale.
GB9418064D0 (en) Medicament administration inhaler
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
FI970331A0 (fi) Lääkkeen antokoostumus virustenvastaisten aineiden nenään toteutettavaa antoa varten
FR2796287B1 (fr) Dispositif d'administration de medicament
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구
IT8820618A0 (it) Forma farmaceutica e supporto per la somministrazione di estratti ellergenici.
GB9724777D0 (en) Intravaginal drug delivery device